Moderate to Severe Bronchiolitis Clinical Trial
Official title:
Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3%
Our study will investigate inhalation therapy of NaCl 3% compared to standard therapy with no inhalation in the treatment of moderate to severe bronchiolitis. The impact on length of hospital stay will be analyzed.
Acute viral bronchiolitis is the most common lower respiratory tract infection in the first
year of life and leads to a large number of hospital admissions. The only recommended
treatment is supportive. However many different types of drug inhalations have been studied
but their efficacy remains controversial.
Our study will compare recommended supportive therapy to supportive therapy combined to
hypertonic saline (NaCl 3%) inhalations in the treatment of moderate to severe
bronchiolitis. This will be the first study to use a true control group with no inhalation.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment